Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693353019 | Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693354013 | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4720581000005110 | heparinoid 0,2 % + salicylsyre 2 % creme | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | dansk modul |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Salicylic acid product | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | keratolytisk middel | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | Salicylic acid (substance) | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | Heparinoid (substance) | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Product containing salicylic acid (medicinal product) | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Product containing heparinoid (medicinal product) | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | middel til topikal anvendelse | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | kutan OG/ELLER transdermal doseringsform | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | Cream | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | Conventional release transdermal cream (dose form) | true | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Count of base of active ingredient | to | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator value | en | false | Inferred relationship | Some | 2 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has precise active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 2 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has basis of strength substance (attribute) | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has precise active ingredient | Heparinoid (substance) | true | Inferred relationship | Some | 1 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has basis of strength substance (attribute) | Heparinoid (substance) | true | Inferred relationship | Some | 1 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator value | to | false | Inferred relationship | Some | 1 | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Heparinoid- and salicylic acid-containing product in transdermal dose form | false | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Heparinoid and salicylic acid only product in transdermal dose form | true | Inferred relationship | Some | ||
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR